Liquid tasimelteon formulations and methods of use thereof
US11759446B2 · kind B2 · utility
0Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2021 |
| Grant date | Sep 19, 2023 |
| Priority date | — |
| Expiry date | Jun 9, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Liquid suspensions of tasimelteon and methods for their use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.